Lofarma is one of the first pharmaceutical companies that has been dedicated to allergies takes care of you since 1945, when lo-Farma S.r.l was established, a pharmaceutical company that focused on research and development of medicinal specialties, then in 1948 changed its name to Laboratorio Farmaceutico LOFARMA S.r.l. and in 1950 began the production of medicines for the diagnosis and treatment of allergic diseases. Finally in 1997 Lofarma transformed into a Joint Stock Company and assumed its current name, Lofarma S.p.A. Lofarma has led generations of allergy physicians to some of the most significant milestones in this science: The first bronchial vaccine, the first nasal vaccine, the Bronchial Hyperactivity Test, to the most recent first monometric allergoid vaccine by the sublingual route.
Lofarma
Our Story
Lofarma Lusitana Limitada is established.
Lofarma is research and technology
Italian pharmaceutical company with you since 1945
Some product lines are the result of intense research and development efforts thanks to the availability of advanced technologies and unique departments, such as the Acarology department where mites are kept and fed with a specific and unique diet that allows for consistent, quality production in compliance with Good Manufacturing Practices.
The batches of mites are then analysed by the Quality and Control laboratory and divided into final batches for diagnostic and therapeutic use.
The knowledge acquired over the years has allowed Lofarma to develop several types of allergy immunotherapies, over 200 tests for allergy diagnosis and numerous products for the prevention of allergies and the treatment of specific diseases.
Lofarma’s technology of allergen in powdered has led to the development of carbamylated monomeric allergoid tablets, a chemically modified allergen for the treatment of allergies.
Given the success of this principle, initially in tablets, the monomeric carbamylated allergoid was also developed in drops and injection form for specific subcutaneous immunotherapy.
Lofarma is international
Italian pharmaceutical company with you for 75 years
Work with us
Transparency of value transfers
- There were no transfers of value related to drugs in 2021.
- There were no transfers of value related to drugs in 2022.
- There were no transfers of value related to drugs in 2023.